De Giglio A, De Biase D, Favorito V, Maloberti T, et al. STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status. Lung Cancer 2025;199:108058.
PMID: 39709652